Further Extension of Continuing Appropriations Act, 2021 became law 658 days after introduction, with cosponsors from both parties
IntroducedMar 5, 2019
ReportedApr 3, 2019
Passed one chamberMay 8, 2019
Passed bothDec 10, 2020
LawDec 22, 2020
What it changes · CRS summary
Written by the Congressional Research Service [2]. 22 words.
Purple Book Continuity Act of 2019 This bill modifies requirements for the Food and Drug Administration to publish information regarding biological products.
Context
- Committees
- House Energy and Commerce Committee
Senate Health, Education, Labor, and Pensions Committee - Policy area
- Economics and Public Finance: 71 of 1,188 bills became law, 113th–118th (6%)
- Sponsor
- 1 of 137 bills enacted since 2013
- Text versions
- 8, from enrolled bill to public law · 252 words
- Subjects
- AppropriationsCongressional oversightDrug safety, medical device, and laboratory regulationExecutive agency funding and structureGovernment information and archivesHealth +1 more
- Latest action
- Dec 22, 2020: Became Public Law No: 116-246.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 5
Each bill appears once, under its strongest link. 5 in all.
Related, per CRS or House · 5
- 116th H.Con.Res. 128 Directing the Clerk of the House of Representatives to make a correction in the enrollment of H.R. 1520. D · Passed both
- 116th H.J.Res. 107 Further Additional Continuing Appropriations Act, 2021 D · Law
- 116th H.J.Res. 110 Extension of Continuing Appropriations Act, 2021 D · Law
- 116th H.R. 19 Lower Costs, More Cures Act of 2019 R · Introduced
- 116th H.Res. 1271 Providing for consideration of the Senate amendment to the bill (H.R. 133) to promote economic partnership and cooperation between the Unite D · Agreed to
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]